Journal profile · RESPIRATORY SYSTEM
Expert Review of Respiratory Medicine
ISSN 1747-6348 · eISSN 1747-6356 · Taylor and Francis Ltd. · UNITED STATES
Expert Review of Respiratory Medicine: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.31; JCR Q2 (journal website); hybrid open access; APC charged, amount not published; median 86 days to acceptance (108 articles, last 24 months); acceptance rate 24% (journal website); 174 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Expert Review of Respiratory Medicine is published by Taylor and Francis Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases and Respiratory Support and Mechanisms, together about 36.1% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Expert Review of Respiratory Medicine [ISSN 1747-6348]; [e-ISSN 1747-6356] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers in the fields of obstructive, restrictive, vascular and infectious respiratory diseases. Respiratory disease imposes a global burden affecting hundreds of millions of people. Around 3 million people die from chronic obstructive pulmonary disease (COPD) each year, making it the 3 rd leading cause of death worldwide, and lower respiratory infections remain the world’s most deadly communicable disease, ranked as the 4 th leading cause of death. Given the intractable nature of the established diseases and emerging threats, such as the rise in allergies and the current global coronavirus pandemic, the importance of respiratory medicine has never been greater. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. Coverage includes the following key areas: Prospects for new and emerging therapeutics and diagnostic methods, including imaging techniques, biomarkers and physiological tests Updates on the status and advances of specific disease areas, including asthma, HIV/AIDS-related disease, cystic fibrosis, COPD and sleep-disordered breathing morbidity Epidemiology of respiratory diseases and preventative strategies, including disease and treatment issues for defined populations, such as children and the elderly All aspects of COPD, from patient self-management to systemic effects of the disease and comorbidities Advances in the treatment of respiratory infections and drug resistance issues Progress in smoking intervention and cessation methods Respiratory intensive and critical care Please note that the journal does not publish case reports, case series, or animal studies. Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees. Reach an international clinical and medical audience alongside other key opinion leaders in your field by publishing with Expert Review of Respiratory Medicine, part of the Expert Collection brand. Read the Instructions for Authors . For any pre-submission enquiries, please contact the Commissioning Editor.
From the journal's Aims & Scope
Research area (LetPub): RESPIRATORY SYSTEM
Editor-in-chief Joseph BlondeauPublisher website
Editorial board by country: 2 in mainland China (about 5%); most named United States 12, United Kingdom 5, France 4, Australia 4, Italy 3 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine14.2%
- Asthma and respiratory diseasesMedicine13.3%
- Respiratory Support and MechanismsMedicine8.7%
- Respiratory and Cough-Related ResearchMedicine6.1%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine5.6%
- Neonatal Respiratory Health ResearchMedicine4.8%
- Cystic Fibrosis Research AdvancesMedicine4.5%
- Inhalation and Respiratory Drug DeliveryMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: yes
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Index Medicus, Journal Citation Reports/Science Edition®
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.31LetPub ·
- Impact factor (publisher) 2025
- 3.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.4Publisher website ·
- CiteScore 2026-06
- 6.3LetPub ·
- CiteScore (publisher) 2025
- 5.1Publisher website ·
- SJR 2026-06
- 0.83LetPub ·
- SJR (publisher) 2025
- 0.77Publisher website ·
- SNIP 2026-06
- 0.84LetPub ·
- SNIP (publisher) 2025
- 0.96Publisher website ·
- h-index
- 34LetPub ·
- h-index
- 76OpenAlex ·
- i10-index
- 1,010OpenAlex ·
- 2-year mean citedness
- 3.13OpenAlex ·
- Self-citation rate
- 3%LetPub ·
- Share of gold OA articles
- 5.28%LetPub ·
Volume
- Articles per year
- 149LetPub ·
- Downloads per year (publisher) 2025
- 384,000Publisher website ·
Articles by year OpenAlex count · 1,997 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 62 | 23 | 17 |
| 2025 | 174 | 52 | 379 |
| 2024 | 98 | 40 | 650 |
| 2023 | 110 | 37 | 954 |
| 2022 | 98 | 39 | 1,153 |
| 2021 | 108 | 35 | 2,255 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
86 daysMedian, submission to acceptance · P25–P75 64 days – 120 days
- Acceptance to online
- median 7 days (108 articles)
- Submission to online
- median 93 days
- Sample
- 108 articles with submission and acceptance dates (261 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher) 2025
- 24%Publisher website ·
- Submission to first decision 2025
- 1 daysPublisher website ·
- First decision after review 2025
- 42 daysPublisher website ·
- Acceptance to publication 2025
- 7 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Not considered
- case reports; case series; animal studies
Article types accepted2
- research articleResearch ArticleLength not stated
- reviewReviewLength not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Expert Review of Respiratory Medicine is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the disco…
Source ↗Publisher website ·- Peer review
No case reports, case series, or animal studies. Model summary
Please note that the journal does not publish case reports, case series, or animal studies.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 1747-6348
- Electronic ISSN
- 1747-6356
- Latest issue on the website
- Volume 20, Issue 9 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Expert Review of Respiratory Medicine
What CAS zone is Expert Review of Respiratory Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Expert Review of Respiratory Medicine is in Zone 3 of Medicine, and in Zone 4 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Expert Review of Respiratory Medicine?
The latest impact factor listed by LetPub is 3.31; CiteScore 6.3, h-index 76.
How long does peer review take at Expert Review of Respiratory Medicine?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 86 days (interquartile range 64–120 days); the journal's website gives an acceptance rate of 24% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Expert Review of Respiratory Medicine in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Where are the editorial board members of Expert Review of Respiratory Medicine based?
Of the 41 board members whose country the journal's board page names, 2 (about 5%) are in mainland China; the countries named most often are United States (12), United Kingdom (5) and France (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Expert Review of Respiratory Medicine?
According to LetPub and DOAJ records, Expert Review of Respiratory Medicine is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Expert Review of Respiratory Medicine open access, and what is the APC?
Expert Review of Respiratory Medicine is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .